R&D
🇪🇺 EMAEMA news and analysis for pharmaceutical BD, investment, and market access
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 1–12 of 37 articles
Quick answer
NovaPharmaNews R&D hub for EMA covers 37 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
EMA Tightens Liver Safety Checks for Tavneos After Fatal Cases
MHRA targets medicine safety with new AI sandbox
BioCryst’s New ORLADEYO Data Adds Real-World HAE Evidence
EMA researchers map AI research priorities across the medicines lifecycle
Europe Drug Prices Face Pressure as U.S. Benchmarking Tightens
EU secures emergency Favipiravir deliveries for hantavirus response
World Lightproof Bottle Opaque Liners Market: Pharma Growth to 2035
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
New EU Template for Clinical Trial Recruitment and Informed Consent: What Pharma Teams Need to Know
Health News Round Up: Diabetes, Vaping, and Biologics – What Pharma Teams Need to Know
Staff Stick: A B2B Guide to the Dual Meaning and Pharma Context
Nika Pharmaceuticals Inc OTCQB NIKA June 2026 Update: Key Developments and Strategic Implications
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.